PIERIS PHARMACEUTICALS, INC.·4

Feb 28, 5:31 PM ET

Mousa Ahmed 4

4 · PIERIS PHARMACEUTICALS, INC. · Filed Feb 28, 2023

Insider Transaction Report

Form 4
Period: 2023-02-24
Mousa Ahmed
Chief Business Officer
Transactions
  • Award

    Stock Option (Right to buy)

    2023-02-24+249,080249,080 total
    Exercise: $1.39Exp: 2033-02-24Common Stock (249,080 underlying)
Footnotes (1)
  • [F1]The option vests as to 25% of the option shares on February 24, 2024 and as to an additional 6.25% of the option shares at the end of each successive three-month period thereafter.

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    230228 FORM 4 (MOUSA)